DUXAP8 and hepatocellular carcinoma: Mechanistic analysis revealed that DUXAP8 activates the MAPK/ERK pathway via competitive binding to miR-584-5p, thereby enhancing globule formation by HCC cells and promoting the expression of stem cell-related genes [121].